Providing educational intervention in waiting room before pediatric provider visit may be beneficial.
The peak level was significantly higher than the average during previous 5 influenza seasons,
Exposure to the 2009 pandemic H1N1 influenza vaccine in pregnancy was not associated with most negative health outcomes among offspring.
According to results from the MINISTONE-2 trial, baloxavir marboxil (Xofluza) was found to be safe and effective in children 1 to less than 12 years old with an influenza infection.
The “Masks Save Lives” campaign is highly effective in preventing nosocomial influenza infection in clinical settings.
The 2018-2019 influenza season was of moderate severity and lasted 21 weeks; illness was mainly attributed to influenza A viruses.
Individuals treated preventively with Xofluza were significantly less likely to develop influenza after exposure to an infected household member.
Whole-genome sequencing was better at identifying nosocomial influenza A outbreak clusters than hemagglutinin (HA)/neuraminidase (NA) gene sequencing.